Archiv
ASH: Early Gene Therapy Promising in Hemophilia (CME/CE)
ORLANDO -- In early clinical trials, a single infusion of a novel viral vector containing a factor IX transgene has enabled one person with hemophilia B to increase clotting factors in his blood and maintain that level for as...[more]
ASH: Clotting Factor Most Often Used Off-Label (CME/CE)
ORLANDO -- More than 90% of recombinant factor VIIa (Novoseven) appears to be used for off-label purposes -- mainly in patients with severe bleeding problems that are not associated with hemophilia, researchers reported here. In...[more]
Red Cross bans people diagnosed with CFS from donating blood
The American Red Cross has announced that it is banning people who have been diagnosed with chronic fatigue syndrome from donating blood as the government undertakes measures to find out whether the condition is caused by the...[more]
Biogen Idec and Swedish Orphan Biovitrum Announce First Patient Dosed in Global Registrational Trial of Long-Lasting Recombinant Factor VIII Fc Fusion Protein
www.biogenidec.com/PRESS_RELEASE_DETAILS.aspx?ID=5981&ReqId=1504351[more]
ASH: New Agent Helpful in Rare Bleeding Disorder (CME/CE)
ORLANDO -- An investigational compound appears to dramatically reduce bleeding episodes among patients with the rare hereditary bleeding disorder known as factor XIII-A deficiency, researcher found. Prophylactic monthly treatment...[more]
Japan confirms highly virulent H5 bird flu strain at poultry farm
The chickens that were suspected of being sick with avian flu at a poultry farm in Japan were confirmed Wednesday by the country's agriculture ministry to have been infected with the deadly H5 bird flu strain. The culling of...[more]
Displaying 15 to 20 of 20
- < Previous
- 1
- 2
- 3